WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Shares Down 8.8% – Should You Sell?

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY)’s stock price dropped 8.8% during mid-day trading on Thursday. The company traded as low as $13.49 and last traded at $13.49. 30,944 shares traded hands during trading, a decline of 56% from the average daily volume of 71,118 shares. The stock had previously closed at $14.79.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded WuXi Biologics (Cayman) to a “hold” rating in a research note on Friday, August 28th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat.com, WuXi Biologics (Cayman) presently has an average rating of “Hold”.

WuXi Biologics (Cayman) Stock Down 6.3%

The firm’s 50 day simple moving average is $12.50 and its 200 day simple moving average is $10.07.

About WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Inc is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company works with pharmaceutical and biotechnology customers to support the development and production of biologic therapies, including monoclonal antibodies, recombinant proteins, vaccines and other complex biological products.

Its services span early-stage discovery and cell-line development through process development, clinical manufacturing, regulatory support and commercial-scale production.